Background: Adipose tissue is an endocrine organ that influences many metabolic processes and accumulates in different depots, including the bone marrow. While the negative associations between visceral fat (VF) or subcutaneous fat (SF) and cardiovascular disease (CVD) risks are well known, the relation between marrow fat (MF) and metabolic risk is unexplored. Objectives: We examined the relations between these three fat depots and whether CVD risks are associated with marrow adiposity. Design: Observational cross-sectional study. Subjects and methods: Computed tomography was used to measure VF, SF and MF depots in 131 healthy young adults (60 females, 71 males; 16-25 years of age). Weight, body mass index (BMI), waist and hip circumferences, blood pressure (BP), carotid intima-media thickness (CIMT) and serum levels of lipids, glucose and insulin were also measured. Results: Regardless of gender, MF was not associated with values of VF or SF, anthropometric measures, or lipid or carbohydrate serum levels (P40.05 for all). In contrast, VF was associated with SF (r values ¼ 0.74 for females, 0.78 for males; both P-values o0.0001) and these depots were related to anthropometric parameters (r values between 0.69 and 0.87; all P-values o0.0001) and to most measures of lipids, glucose or insulin (r values between 0.25 and 0.62). Conclusions: Marrow adiposity in young men and women is independent of VF and SF, and is not associated with CVD risk. These findings do not support the concept that marrow adiposity is involved in the comorbidities related to fat accumulation in other compartments.
Introduction
Fat tissue is a complex endocrine organ, secreting multiple hormones, influencing many metabolic processes, and amassing at various sites, including the subcutaneous and intra-abdominal tissues and the marrow cavity of bones. In excess, it gives rise to several comorbidities. 1 A wealth of epidemiologic data links a growing number of negative health outcomes, such as hypertension, insulin resistance, type 2 diabetes, dyslipidemia, the metabolic syndrome and cardiovascular disease (CVD) risk to the progressive accumulation of fat. Despite differences in histology, physiology and gene expression profile among fat depots, it is generally believed that excessive fat accumulation at any site has similar negative health connotations. [2] [3] [4] [5] For example, both intra-abdominal and subcutaneous fat (SF) depots are related to insulin resistance and dyslipidemia, albeit to different degrees. [6] [7] [8] [9] [10] We recently found an inverse relation between fat in the marrow cavity and the amount of bone in the skeleton of young healthy patients. Unexpectedly, there were no relations between measures of marrow adiposity with weight, body mass index (BMI) or total body fat as measured by dual energy X-ray absorptiometry. 11 These findings suggest that marrow fat (MF) may be an independent fat compartment with potentially different metabolic functions; consistent with studies in animal models reporting no relation between body size or insulin secretion and marrow adiposity. 12 However, the possible association between MF and blood pressure (BP), measures of carotid wall thickness and carbohydrate or lipid metabolism in humans is largely unexplored, and no previous study has assessed the relation between marrow adiposity and CVD risk factors. We examined the relations between MF and subcutaneous and visceral adiposity using computed tomography (CT) and between MF and BP, carotid wall thickness, fasting levels of insulin, glucose and lipids in healthy young males and females.
Patients and methods

Patients
The participants were 131 healthy young adults (60 females, 71 males; 16-24.9 years of age) who were recruited from schools and colleges in the Los Angeles area. The investigational protocol was approved by the hospital institutional review board and informed consent was obtained. Candidates for this study were excluded if they had a diagnosis of any underlying disease or chronic illness, if they had been ill for 42 weeks during the previous 6 months, if they had been admitted to the hospital at any time during the previous 3 years or if they were taking any medications regularly. Females who were pregnant were also excluded. All potential candidates underwent a physical examination by a pediatric endocrinologist and only those who had achieved sexual maturity (Tanner stage V of sexual development) were included. 13 Thereafter, height, weight, BP, BMI, waist and hip circumferences and the waist-to-hip ratio were determined. The waist-to-hip ratio was calculated as a surrogate of central adipose distribution.
Carotid ultrasonography
All studies were acquired by the same specialized ultrasound (US) technologist using the Acuson Sequoia 512 mainframe (Acuson Corp., Malvern, PA, USA) equipment and a highresolution 15L8 MHz linear-array transducer following a predetermined standardized scanning protocol. The patients were studied in the supine position with the head turned slightly toward the side examined. Images of the arterial wall were obtained from the posterior walls of both common carotids 1 cm below the carotid bulb (bifurcation) during three complete and independent cardiac cycles. An automated computerized edge detection software package developed by Siemens (Siemens Medical Solutions USA, Malvern, PA, USA) was used to determine carotid intima-media thickness (CIMT) values in the frames of each cycle depicting the narrowest and widest vessel diameters. The mean measure obtained from three independent cardiac cycles at the maximum and minimum arterial diameters in both carotids was used for analysis. All examinations were digitally stored and analyzed by the same researcher. The intraclass correlations for CIMT determinations obtained in three different cardiac cycles are between 0.92 and 0.98. 14 
Blood pressure
Readings of BP were taken after a 10-min rest using a standard mercury sphygmomanometer (Critikon Dura-cuf, GE Medical Systems, WI, Waukesha, USA) immediately before, and immediately following, the US examination.
The patient was as relaxed as possible and was instructed not to talk during the measurement procedure. BP was measured in a supine position from the right and left brachial arteries below the level of the right atrium, and the average of all these readings was used for analysis. ) were obtained at the umbilical level. For the purpose of this study, SF was defined as the amount of adipose tissue located between the skin and the rectus muscles of the abdomen, the external oblique muscles, the broadest muscles of the back and the erector muscles of the spine at the level of the umbilicus. VF was defined as the intraabdominal adipose tissue surrounded by the rectus muscles of the abdomen, the external oblique muscles, the lumbar quadrate muscle, the psoas muscles and the lumbar spine at the same level. Measures of the fat density (FD) of the marrow canal were obtained at the midshaft of the femurs.
Computed tomography numbers express the measure of the linear attenuation of the X-ray beam through the medium in that space and are defined as Hounsfield units (HU), using the linear attenuation coefficient of water (HU ¼ 0) and air (HU ¼ À1000); using these parameters, HU for fat fall between a range of negative values. 16 For the purpose of this study, CT values for FD in HU were converted into density values (g cm
À3
) based on previously published studies that calculated CT attenuation values for human tissues, including adipose tissue. [17] [18] [19] Specifically, HU measures for all patients were converted into mass density using a function taken from Schneider et al. 17 for CT ranges between À98 and 14; density ¼ (1.018 þ 0.893 Â 10 À3 HU) (g cm À3 ). It should be stressed that, as marrow is comprised of hematopoietic tissue ( þ HU) with a density of 1.06 g cm
, and fatty tissue (ÀHU) with a density of 0.92 g cm
, the higher the density of marrow tissue the lower the fraction of MF. 17 This fraction changes during growth and throughout
Marrow adiposity and cardiovascular risk N Di Iorgi et al life in a predictable and orderly age-, bone-and site-specific manner. [20] [21] [22] In contrast to the vertebral body and the metaphyseal regions of the long bones, the shaft of the femur contains no trabecular bone. In addition, by 15 years of age, the marrow in the shaft of the long bones is mostly comprised of fat, and CT values for the density of the marrow at this site mainly reflect the tissue density of fat; although from menarche to menopause females are known to have more hematopoietic tissue in the marrow. 23, 24 Hence, to avoid the confounding effects of blood conversion and trabecular bone, we chose to analyze the shaft of the long bones. Intra-and inter-coefficients of variation for repeated measurements of VF and SF ranged from 1.5 to 3.5% and were 1% for FD.
11,25
Biochemical determinations After an overnight fast, blood samples were obtained. Glucose was analyzed by the Ortho vitros 950 by dry chemistry method and insulin by the Magic Light analyzer by immunochemiluminometric assay that utilizes paired antibodies selectively reactive to intrinsic insulin. The lipid profiles, including measures of triglycerides, total cholesterol and low-, very low-and high-density lipoproteins, respectively, were determined using a direct measurement method for the enzymatic determination of cholesterol esters. 26 Cardio-sensitive reactive protein was measured by latexenhanced nephelometry. Using the Homeostasis Model Assessment (HOMA-IR) formula (insulin (mU l
À1
) Â glucose (mmol l À1 ))/22.5, insulin resistance was calculated. 27 The ratio between high-to-low lipoproteins was determined as surrogate of dyslipidemia (low-density lipoprotein þ very low-density lipoprotein/high-density lipoprotein). Regardless of gender, VF and SF were significantly associated with each other (r values ¼ 0.74 for females, 0.78 for males; both P-values o0.0001) and were each strongly related to weight, BMI, waist and hip circumferences, insulin, triglycerides and the low-to-high density lipoprotein ratio. Significant associations were found between VF and 
Statistical analyses
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CIMT measures in males, but not in females (Table 2 ). In contrast, marrow adiposity was not related to measures of VF or SF, to any anthropometric parameters (Figure 1 ), to CIMT values or to any biochemical measures of carbohydrates or lipid metabolism (Tables 2 and 3) ; this was true for males and females (P ¼ NS for all correlations). No significant associations were found between any of the three fat compartments and values for systolic or diastolic BP (r values between À0.20 and 0.11) or inflammatory profile; although cardio-sensitive reactive protein and VF showed a trend towards significance in both genders (both P-values ¼ 0.06) ( Table 2) . Multivariate regression analyses indicated that both BMI and HOMA-IR independently predicted SF in males, and that BMI and the low-to-high density lipoprotein ratio independently predicted VF in both females and males (Table 3) .
Discussion
Ample data indicate that the expansion of body fat has tremendous implications for metabolic health and is strongly associated with dyslipidemia and insulin resistance. However, compared to subcutaneous or abdominal fat depots, the relations between marrow adiposity and metabolic risk factors are largely unknown. In our study, we found that in healthy young males and females, CT measures of marrow adiposity at the midshaft of the femurs were not Marrow adiposity and cardiovascular risk N Di Iorgi et al related to any anthropometric parameters or surrogates of adiposity, such as the waist-to-hip ratio, or to the amount of visceral or SF. Moreover, marrow adiposity was not associated with BP, measures of carotid wall thickness, fasting glucose, fasting insulin, insulin resistance or lipid profile. To our knowledge, no previous study has assessed the relation between marrow adiposity and CVD risk factors. In contrast, similar to others and as expected, we found that visceral and SF compartments were strongly associated with each other and with anthropometric and biochemical measures of metabolic risk. BMI was the main predictor of these two fat depots, accounting for more than 50 and 70% of the variance of visceral and SF, respectively, regardless of gender. Moreover, HOMA-IR predicted 1.8% of the variance of SF in males, whereas the low-to-high lipoprotein ratio was predictive of VF in both females and males; 5.7 and 6.0%, respectively.
Our findings are consistent with previous studies in animal models indicating that MF is not affected by insulin or long periods of starvation. 12, 28 They are also in agreement with two previous studies in humans showing a lack of association between marrow adiposity and anthropometric or abdominal fat depots measures; 29, 30 these investigations used a combination of dual energy X-ray absorptiometry to measure abdominal adiposity and magnetic resonance techniques or histology to evaluate MF, whereas in this study, we used CT to analyze this relation. Although no clinical investigations have previously assessed the relationships between marrow adiposity and energy metabolism, there is anecdotal evidence that MF may be metabolically independent of other fat compartments. Indeed, the progressive loss of body weight in anorexia is associated with an increased amount of fat in the marrow, at least until extreme levels of thinness. 31 Similarly, acquired lypodystrophy leads to a massive loss of body fat, specifically, of SF in the hips and thighs, and to a lesser degree, of VF, yet marrow adiposity remains preserved. 32 Previous findings by us and others indicate marrow adiposity to be reciprocally related to the amount of bone in both the axial and the appendicular skeleton. 11, 30, [33] [34] [35] Whether marrow and extraskeletal adipocytes arise from different clonal cells or share a common progenitor that undergoes specific proliferation and differentiation based on location is yet to be elucidated. In this regard, the superficial and deep SF depots in swine were found to arise from two different progenitors, the perifollicular stromal cells and the mesenchyme, respectively. 36 The use of sophisticated imaging technology, the inclusion of both genders, the evaluations of multiple adiposity and metabolic biochemical measures and the examination of a homogeneous cohort of teenagers and young adults are strengths of this study. The cross-sectional design is a major limitation, and further investigations will be needed to establish why skeletal and extraskeletal adiposity are not related. Although in this study we did not assess key determinants of fat accumulation, such as dietary and alcohol intake, as weight, BMI, waist circumference, hip circumference or their ratio were not related to MF, it is unlikely that these variables influenced our results. In addition, our results are limited to young adults who were not overly obese (BMI 436) and cannot be extrapolated to other age groups or populations. Lastly, while CT determinations of FD have not been validated in the same individuals with histomorphometry, previous in vitro studies have assessed the accuracy of CT measures of marrow adiposity. 37 In conclusion, marrow adiposity in the femurs of healthy teenagers and young adults is not related to VF or SF depots, or to metabolic or CVD risk factors. Our findings support the notion that the negative metabolic health outcomes known to be associated with obesity are independent of MF. Marrow adiposity and cardiovascular risk N Di Iorgi et al
